The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Pro-Differentiation Effect of Doxycycline on Human SZ95 Sebocytes
Abstract
Background: Despite their widespread clinical use in both acne vulgaris and rosacea, the effects of tetracyclines on sebocytes have not been investigated until now. Sebaceous glands are central to the pathogenesis of acne and may be important in the development of rosacea. Objective: The aim of this study was to assess the effects of doxycycline on the immortalized SZ95 sebaceous gland cell line as a model for understanding possible effectiveness on the sebaceous glands in vivo. Methods: The effects of doxycycline on SZ95 sebocyte numbers, viability, and lipid content as well as its effects on the mRNA levels of peroxisome proliferator-activated receptors α and γ, in comparison to the peroxisome proliferator-activated receptor γ agonist troglitazone, were investigated. Results: Doxycycline reduced the cell number and increased the lipid content of SZ95 sebocytes in vitro after 2 days of treatment. These doxycycline effects may be explained by an upregulation of peroxisome proliferator-activated receptor γ mRNA levels at 12 and 24 h, whereas troglitazone already upregulated peroxisome proliferator-activated receptor γ levels after 6 h. Both compounds did not influence peroxisome proliferator-activated receptor α mRNA levels. Conclusion: These new findings illustrate a previously unknown effect of doxycycline on sebocytes, which may be relevant to their modulation of disorders of the pilosebaceous unit, such as acne vulgaris and rosacea.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Minocycline may partially converge on this axis by enhancing retinoid signaling and p53 activity, while related tetracyclines such as doxycycline have been shown to decrease SZ95 proliferation and promote differentiation [50].”
From Dissolvable silk microneedles delivering minocycline-loaded ZIF-8 nanoparticles for targeted modulation of sebocyte metabolism and improved acne therapy (2026) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
Alestas, T., Ganceviciene, R., Fimmel, S., Müller-Decker, K., & Zouboulis, C. C. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0715-8 · Cited by 269
Self-citationPeroxisome Proliferator-Activated Receptors Increase Human Sebum Production
Trivedi, N. R., Cong, Z., Nelson, A. M., Albert, A. J., Rosamilia, L. L., Sivarajah, S., Gilliland, K. L., Liu, W., Mauger, D. T., Gabbay, R. A., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700336 · Cited by 184
Research works printed but not linked: 11
- 10.1016/j.jaad.2005.10.004 · DOI · Paper page
- 10.1111/jdv.12298 · DOI · Paper page
- 10.1111/j.1365-2133.2011.10662.x · DOI · Paper page
- 10.1016/j.bcp.2017.04.030 · DOI · Paper page
- 10.1093/jac/dkl224 · DOI · Paper page
- 10.1046/j.1523-1747.1999.00771.x · DOI · Paper page
- 10.1111/1523-1747.ep12526131 · DOI
- 10.1001/archderm.139.4.459 · DOI · Paper page
- 10.1046/j.1523-1747.2003.12411.x · DOI · Paper page
- 10.1046/j.1523-1747.1999.00487.x · DOI
- 10.1016/0005-2760(96)00066-5 · DOI · Paper page
Cited by
Yang, X., Ruan, D., Ye, F., Qiu, X., Li, S., Huang, L., Zouboulis, C. C., Mo, X., Jiang, X., & Ju, Q. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04221-8 · Cited by 4
Self-citation
Metadata
- Authors
- Zouboulis, C. C., Ní Raghallaigh, S., Schmitz, G., & Powell, F. C.
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2020-10-22
- Volume
- 237
- Issue
- 5
- Pages
- 792-796
- ISSN
- 1018-8665
- 1421-9832
- Cited by
- 5
- References
- 3
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Pro-Differentiation Effect of Doxycycline on Human SZ95 Sebocytes. https://app.cochat.ai/papers/10.1159/000510885
- The paper
- Zouboulis, C. C., Ní Raghallaigh, S., Schmitz, G., & Powell, F. C. (2021). The Pro-Differentiation Effect of Doxycycline on Human SZ95 Sebocytes. Dermatology. https://doi.org/10.1159/000510885
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.